Misonix Inc (MSON, Financial) files its latest 10-K with SEC for the fiscal year ended on June 30, 2019. Misonix Inc designs, manufactures, markets and develops minimally invasive ultrasonic surgical device products. Its products include the BoneScalpel surgical system, the SonaStar Surgical Aspirator and the SonicOne Wound Cleansing and Debridement System. Misonix Inc has a market cap of $190.340 million; its shares were traded at around $19.73 with and P/S ratio of 4.84.
For the last quarter Misonix Inc reported a revenue of $9.75 million, compared with the revenue of $8.64 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $38.8 million, an increase of 5.9% from last year. For the complete 30-year financial data, please go here.. For the last five years Misonix Inc had an average revenue growth rate of 18% a year.
The reported loss per diluted share was 79 cents for the year, compared with the loss per share of $0.69 in the previous year. The Misonix Inc had an operating margin of -19.07%, compared with the operating margin of -8.02% a year before. The 10-year historical median operating margin of Misonix Inc is -23.14%. The profitability rank of the company is 3 (out of 10).
At the end of the fiscal year, Misonix Inc has the cash and cash equivalents of $7.84 million, compared with $11.0 million in the previous year. The company had no long term debt. Misonix Inc has a financial strength rank of 10 (out of 10).
At the current stock price of $19.73, Misonix Inc is traded at 93.4% premium to its historical median P/S valuation band of $10.20. The P/S ratio of the stock is 4.84, while the historical median P/S ratio is 2.49. The stock gained 2.23% during the past 12 months.
Directors and Officers Recent Trades:
- COO Sharon W Klugewicz bought 500 shares of MSON stock on 08/20/2019 at the average price of $20.78. The price of the stock has decreased by 5.05% since.
For the complete 20-year historical financial data of MSON, click here.